Vident Advisory’s Sanofi SNY Stock Holding History

Vident Advisory’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.9M	Sell	302,447 -49,505	-14%	-$2.21M	0.09%	205
2026 Q1	$17M	Buy	351,952 +112,374	+47%	+$5.24M	0.14%	125
2025 Q4	$11.6M	Buy	239,578 +48,049	+25%	+$2.38M	0.11%	170
2025 Q3	$9.04M	Buy	191,529 +64,398	+51%	+$3.11M	0.09%	209
2025 Q2	$6.14M	Buy	127,131 +111,571	+717%	+$5.7M	0.07%	226
2025 Q1	$863K	Buy	15,560 +1,994	+15%	+$108K	0.01%	787
2024 Q4	$654K	Sell	13,566 -792	-6%	-$40.3K	0.01%	825
2024 Q3	$827K	Buy	14,358 +956	+7%	+$51.6K	0.02%	700
2024 Q2	$650K	Buy	13,402 +145	+1%	+$7K	0.02%	763
2024 Q1	$644K	Sell	13,257 -4,315	-25%	-$211K	0.01%	716
2023 Q4	$874K	Buy	17,572 +899	+5%	+$44K	0.02%	602
2023 Q3	$894K	Buy	+16,673	New	+$889K	0.03%	549

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vident Advisory's SNY Position: Q2 2026 in Review

Vident Advisory reduced its Sanofi (SNY) stake by 14% in Q2 2026, selling an estimated $2.21M and leaving 302,447 shares worth $12.9M. The position accounts for 0.09% of the portfolio, ranked #205.

Vident Advisory first reported a position in SNY in Q3 2023 and has held it in 12 quarters since. The position peaked at $17M in Q1 2026. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

Vident Advisory held 302,447 shares of Sanofi worth $12.9M as of Q2 2026.
Vident Advisory sold 49,505 Sanofi shares in Q2 2026, an estimated $2.21M.
Sanofi made up 0.09% of Vident Advisory's portfolio in Q2 2026, its #205 holding.
Vident Advisory first reported a position in Sanofi in Q3 2023 and has held it in 12 quarters since.
Vident Advisory's Sanofi position peaked at $17M in Q1 2026.
718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.